This document discusses pharmaceutical packaging materials. It begins by defining pharmaceutical packaging and listing the key characteristics packaging materials must have, such as protecting the product from environmental conditions and not being reactive.
It then describes the different types of packaging - primary, secondary, and tertiary. Primary packaging is in direct contact with the product, secondary protects both the primary and product, and tertiary is removed before retail display.
The document goes on to classify packaging materials and containers. It discusses common materials like glass, plastic, and metals, providing details on types within each category. It also covers biological testing and considerations for drug-plastic interactions. In closing, it thanks the audience and cites references used.
EVULATION OF PHARMACUTICAL PACAKGING MATERIALS/EVULATION PARAMETERS OF PAKAGI...Ashwani Kumar Singh
This document discusses the evaluation of various packaging materials used for pharmaceutical products. It describes the key characteristics packaging must have including protecting the product from environmental factors while being non-reactive, non-toxic, and FDA approved. Common packaging materials like glass, plastic, and metal are outlined. Specific tests are provided to evaluate each material for qualities like chemical resistance, water permeability, and fragmentation resistance to ensure product safety and stability.
This document discusses quality control tests for pharmaceutical packing materials. It describes the different types of primary, secondary, and tertiary packing materials used in the pharmaceutical industry. It focuses on quality control tests for various container materials like glass and plastic. Some key tests discussed for glass containers include chemical resistance testing, hydrolytic resistance testing, surface etching testing, and light transmission testing. For plastic containers, leakage testing, collapsibility testing, clarity of aqueous extract testing, and non-volatile residue testing are described. The document provides details on procedures and acceptance criteria for many of these important quality control tests.
This document discusses quality control tests for packaging materials used in the pharmaceutical industry. It begins with definitions of packaging, quality control, and the different categories of packaging materials. It then describes common materials used for primary packaging like containers and closures, and secondary packaging. The rest of the document outlines specific quality control tests performed on these materials, including chemical resistance testing, hydrolytic resistance testing, and tests for containers, closures, and secondary packaging materials.
quality control test for containers, closures and secondary packing materials...SureshPharamasivam
This document discusses various aspects of pharmaceutical packaging. It begins by defining primary, secondary, and tertiary packaging. The objectives of packaging include marketing, identification, protection, and convenience. Selection of packaging depends on factors like content stability and compatibility. Common packaging materials include glass, plastic, rubber, metals, and paper. The document then discusses various packaging types like containers, closures, collapsible tubes, and unit dose packaging. It outlines tests for evaluating different packaging materials and provides an overview of FDA regulations for pharmaceutical packaging.
Quality control test: Containers, Closures and Secondary packing materialsPranali Polshettiwar
This document summarizes quality control tests for containers, closures, and secondary packaging materials. It describes common materials used for each, such as glass, plastic, metal for containers and rubber, plastic, metal for closures. Key quality tests for containers include powdered glass test, water attack test, hydrolytic resistance test, and thermal shock test. Tests for closures include residue on evaporation, pH of extract, and sterility. Secondary packaging materials like paper and cardboard are also tested for quality.
Pharmaceutical packaging serves several important functions:
1) It protects drugs from external environmental factors like light, moisture, and contamination.
2) Packaging identifies drug products, provides instructions for proper use, and ensures safety and efficacy.
3) Packaging types include bottles, blister packs, vials, and other containers/closures that are evaluated through testing to ensure sterility, integrity, and that they do not interact with drug contents.
This document discusses pharmaceutical packaging materials. It begins by defining pharmaceutical packaging and listing the key characteristics packaging materials must have, such as protecting the product from environmental conditions and not being reactive.
It then describes the different types of packaging - primary, secondary, and tertiary. Primary packaging is in direct contact with the product, secondary protects both the primary and product, and tertiary is removed before retail display.
The document goes on to classify packaging materials and containers. It discusses common materials like glass, plastic, and metals, providing details on types within each category. It also covers biological testing and considerations for drug-plastic interactions. In closing, it thanks the audience and cites references used.
EVULATION OF PHARMACUTICAL PACAKGING MATERIALS/EVULATION PARAMETERS OF PAKAGI...Ashwani Kumar Singh
This document discusses the evaluation of various packaging materials used for pharmaceutical products. It describes the key characteristics packaging must have including protecting the product from environmental factors while being non-reactive, non-toxic, and FDA approved. Common packaging materials like glass, plastic, and metal are outlined. Specific tests are provided to evaluate each material for qualities like chemical resistance, water permeability, and fragmentation resistance to ensure product safety and stability.
This document discusses quality control tests for pharmaceutical packing materials. It describes the different types of primary, secondary, and tertiary packing materials used in the pharmaceutical industry. It focuses on quality control tests for various container materials like glass and plastic. Some key tests discussed for glass containers include chemical resistance testing, hydrolytic resistance testing, surface etching testing, and light transmission testing. For plastic containers, leakage testing, collapsibility testing, clarity of aqueous extract testing, and non-volatile residue testing are described. The document provides details on procedures and acceptance criteria for many of these important quality control tests.
This document discusses quality control tests for packaging materials used in the pharmaceutical industry. It begins with definitions of packaging, quality control, and the different categories of packaging materials. It then describes common materials used for primary packaging like containers and closures, and secondary packaging. The rest of the document outlines specific quality control tests performed on these materials, including chemical resistance testing, hydrolytic resistance testing, and tests for containers, closures, and secondary packaging materials.
quality control test for containers, closures and secondary packing materials...SureshPharamasivam
This document discusses various aspects of pharmaceutical packaging. It begins by defining primary, secondary, and tertiary packaging. The objectives of packaging include marketing, identification, protection, and convenience. Selection of packaging depends on factors like content stability and compatibility. Common packaging materials include glass, plastic, rubber, metals, and paper. The document then discusses various packaging types like containers, closures, collapsible tubes, and unit dose packaging. It outlines tests for evaluating different packaging materials and provides an overview of FDA regulations for pharmaceutical packaging.
Quality control test: Containers, Closures and Secondary packing materialsPranali Polshettiwar
This document summarizes quality control tests for containers, closures, and secondary packaging materials. It describes common materials used for each, such as glass, plastic, metal for containers and rubber, plastic, metal for closures. Key quality tests for containers include powdered glass test, water attack test, hydrolytic resistance test, and thermal shock test. Tests for closures include residue on evaporation, pH of extract, and sterility. Secondary packaging materials like paper and cardboard are also tested for quality.
Pharmaceutical packaging serves several important functions:
1) It protects drugs from external environmental factors like light, moisture, and contamination.
2) Packaging identifies drug products, provides instructions for proper use, and ensures safety and efficacy.
3) Packaging types include bottles, blister packs, vials, and other containers/closures that are evaluated through testing to ensure sterility, integrity, and that they do not interact with drug contents.
This document discusses pharmaceutical packaging materials and quality control testing. It defines primary, secondary, and tertiary packaging. Common materials used include glass, plastic, rubber, and paper. Quality control tests are described for glass including powdered glass and water attack tests. Plastic container tests include leakage, collapsibility, water vapor permeability, and transparency. Rubber closure tests include fragmentation, self-sealability, extractive, and compatibility testing. Proper packaging protects pharmaceutical products and quality testing ensures the materials are suitable for drug products.
This document discusses the selection and evaluation of pharmaceutical packaging materials. It begins by defining packaging and its purposes of providing protection, identification, convenience, and compliance for products. Key factors in selecting packaging materials include the type of container, product characteristics, and characteristics of the materials themselves like barrier properties and FDA approval. Common container materials like glass, plastic, and metal are described along with their advantages. The document also discusses evaluating packaging materials through tests like leakage tests, collapsibility tests, and permeability tests to ensure suitability for drug products.
This document discusses pharmaceutical packaging materials and quality control testing. It defines primary, secondary, and tertiary packaging. Common packaging materials include glass, plastic, paper, and boards. Quality control tests for glass containers include chemical resistance via powdered glass and water attack tests. Tests are also described for plastic containers, including clarity of extract and non-volatile residue. The document concludes that testing packaging materials is important to ensure the quality, stability, and efficacy of drug products.
Quality control test for containers and closure Pratik Ghivepratikghive82
Quality control test for containers and closure Pratik Ghive covers all aspects in details in sample language with animated images of containers for better understanding
Quality control of packaging material.pptxEasy Concept
The selection of package begins with determination of products physical & chemical characteristics.
Quality control of a packaging component starts at design stage. All the aspects of a pack development may give rise to quality problems. It must be identified & minimized by performing quality control tests.
This document discusses quality control tests for containers, closures, and packaging materials. It outlines various tests for glass and plastic containers like powdered glass test, water attack test, and water vapor permeability test. Tests are described for checking properties like resistance to heat and pressure. Quality control tests for closures ensure sterility, lack of fragmentation, and proper sealing. These tests are important to ensure the packaging protects the drug product during storage, transport, and use.
Quality control test for containers and closuresHenisha Patel
This document discusses quality control tests for containers, closures, and packaging materials. It outlines various tests for glass and plastic containers like powdered glass test, water attack test, and water vapor permeability test. Tests are also described for closures, including fragmentation test, sterility test, and tests for properties like pH and reducing substances of aqueous extracts of closures. Various types of primary, secondary, and tertiary packaging are also mentioned, along with quality control tests for blister packs and strips to check for proper sealing and prevention of moisture ingress.
PACKAGING MATERIAL QUALITY CONTROL TEST AND OPERATION.pdfMayuriPawar98
packaging operation in pharmaceutical industry and material used types and quality control tests,types of container closure system ,recent trends in pharmaceutical packaging
This document summarizes quality control tests for various pharmaceutical packaging materials including containers, closures, and secondary packaging. It discusses tests for glass, plastic, metal containers as well as rubber, plastic, and metal closures. Specific tests covered include chemical resistance, hydrolytic resistance, arsenic, thermal shock, internal bursting pressure, leakage, transparency, water vapor permeability, and more. Flexible packaging materials like polyethylene, cast polypropylene, bi-oriented polypropylene, polyester, and polyamide are also summarized. The document aims to present an overview of important quality control testing for ensuring the safety and integrity of pharmaceutical packaging.
Selection and Evaluation of Pharmaceutical packaging materials and.pptxAbhishekVinod8
The document discusses various packaging materials used in the pharmaceutical industry including glass, plastic, and metal containers as well as different types of closures. It provides details on the properties, types, evaluation, and testing of these packaging materials to ensure they are suitable for holding pharmaceutical products and meeting regulatory standards. Selection of the appropriate packaging material is based on factors like the route of administration, physical form of the product, stability requirements, and cost considerations.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Quality control of packaging materials."
Thank you for reading.
we hope it was helpful to you.
UIPS,PU team
This document discusses quality control testing standards and procedures for pharmaceutical packaging materials. It outlines tests for various packaging components like glass containers, plastic packaging, and rubber stoppers. Key tests described include appearance and dimensional checks, compatibility testing, chemical resistance tests like powdered glass tests and water attack tests, sterility validation tests for sterile products, and non-sterile product validation tests. The document emphasizes that quality control testing is important to ensure packaging and components are defect-free and can safely contain drug products.
This document discusses quality control testing for packaging materials, specifically glass and plastic containers. It defines quality control and the different types of packaging (primary, secondary, tertiary). It then describes various quality control tests performed on glass containers, including tests for chemical resistance, hydrolytic resistance, thermal shock resistance, and tests for containers used for injectable preparations. Similar tests are described for plastic containers, with the overall goal of ensuring packaging materials meet specifications before use to protect drug quality, stability, and efficacy.
The document discusses various quality control tests performed on pharmaceutical packaging materials like glass containers, closures, collapsible tubes, metallic tins, strips, blisters, and paper and board. It describes tests such as chemical resistance testing, hydrolytic resistance testing, arsenic testing, thermal shock testing, internal bursting pressure testing, and leakage testing for glass containers. Similar tests are described for other packaging materials to check properties like sterility, fragmentation resistance, self-sealability, dimensions, cleanliness, and moisture penetration resistance. The purpose of these tests is to ensure that the packaging materials meet quality standards and do not interact or leach components that can contaminate the pharmaceutical products stored within.
This document discusses quality control tests for various pharmaceutical packaging materials including glass containers, closures, collapsible tubes, metallic tins, strips, blisters, and paper/board. It describes tests to evaluate the chemical resistance, hydrolytic resistance, arsenic content, thermal shock resistance, internal bursting pressure, and leakage of glass containers. Similar tests are described for evaluating the sterility, fragmentation, self-sealability, pH, light absorption, and residue of closures. Tests for collapsible tubes include leakage testing, collapsibility testing, and lacquer curing/compatibility. Dimensional measurements and cleanliness checks are discussed for metallic tins. Vacuum testing is described for quality control of strips and
Qc test for plastics,metallic tins,closures, collapsible tubes, secondary pac...himanshu kamboj
b pharma 6th sem
pharmaceutical quality assurance
Introduction
Types of pharmaceutical packaging
Packaging materials
Quality control test for plastic
Quality control test for closures
Quality control of collapsible tubes
Quality control of metallic tins
QC test for secondary packaging materials
This document discusses quality control testing for various packaging materials used in the pharmaceutical industry, including glass, plastic, paper/cardboard, rubber, metals and foils. It provides details on specific tests for each material. For example, for glass it describes light transmission testing, hydrolytic resistance testing and powdered glass testing. For plastic, it outlines leakage testing, collapsibility testing and water vapor permeability testing. The document aims to guide testing to ensure that packaging materials meet quality standards.
This document discusses pharmaceutical packaging materials and quality control testing. It defines primary, secondary, and tertiary packaging. Common materials used include glass, plastic, rubber, and paper. Quality control tests are described for glass including powdered glass and water attack tests. Plastic container tests include leakage, collapsibility, water vapor permeability, and transparency. Rubber closure tests include fragmentation, self-sealability, extractive, and compatibility testing. Proper packaging protects pharmaceutical products and quality testing ensures the materials are suitable for drug products.
This document discusses the selection and evaluation of pharmaceutical packaging materials. It begins by defining packaging and its purposes of providing protection, identification, convenience, and compliance for products. Key factors in selecting packaging materials include the type of container, product characteristics, and characteristics of the materials themselves like barrier properties and FDA approval. Common container materials like glass, plastic, and metal are described along with their advantages. The document also discusses evaluating packaging materials through tests like leakage tests, collapsibility tests, and permeability tests to ensure suitability for drug products.
This document discusses pharmaceutical packaging materials and quality control testing. It defines primary, secondary, and tertiary packaging. Common packaging materials include glass, plastic, paper, and boards. Quality control tests for glass containers include chemical resistance via powdered glass and water attack tests. Tests are also described for plastic containers, including clarity of extract and non-volatile residue. The document concludes that testing packaging materials is important to ensure the quality, stability, and efficacy of drug products.
Quality control test for containers and closure Pratik Ghivepratikghive82
Quality control test for containers and closure Pratik Ghive covers all aspects in details in sample language with animated images of containers for better understanding
Quality control of packaging material.pptxEasy Concept
The selection of package begins with determination of products physical & chemical characteristics.
Quality control of a packaging component starts at design stage. All the aspects of a pack development may give rise to quality problems. It must be identified & minimized by performing quality control tests.
This document discusses quality control tests for containers, closures, and packaging materials. It outlines various tests for glass and plastic containers like powdered glass test, water attack test, and water vapor permeability test. Tests are described for checking properties like resistance to heat and pressure. Quality control tests for closures ensure sterility, lack of fragmentation, and proper sealing. These tests are important to ensure the packaging protects the drug product during storage, transport, and use.
Quality control test for containers and closuresHenisha Patel
This document discusses quality control tests for containers, closures, and packaging materials. It outlines various tests for glass and plastic containers like powdered glass test, water attack test, and water vapor permeability test. Tests are also described for closures, including fragmentation test, sterility test, and tests for properties like pH and reducing substances of aqueous extracts of closures. Various types of primary, secondary, and tertiary packaging are also mentioned, along with quality control tests for blister packs and strips to check for proper sealing and prevention of moisture ingress.
PACKAGING MATERIAL QUALITY CONTROL TEST AND OPERATION.pdfMayuriPawar98
packaging operation in pharmaceutical industry and material used types and quality control tests,types of container closure system ,recent trends in pharmaceutical packaging
This document summarizes quality control tests for various pharmaceutical packaging materials including containers, closures, and secondary packaging. It discusses tests for glass, plastic, metal containers as well as rubber, plastic, and metal closures. Specific tests covered include chemical resistance, hydrolytic resistance, arsenic, thermal shock, internal bursting pressure, leakage, transparency, water vapor permeability, and more. Flexible packaging materials like polyethylene, cast polypropylene, bi-oriented polypropylene, polyester, and polyamide are also summarized. The document aims to present an overview of important quality control testing for ensuring the safety and integrity of pharmaceutical packaging.
Selection and Evaluation of Pharmaceutical packaging materials and.pptxAbhishekVinod8
The document discusses various packaging materials used in the pharmaceutical industry including glass, plastic, and metal containers as well as different types of closures. It provides details on the properties, types, evaluation, and testing of these packaging materials to ensure they are suitable for holding pharmaceutical products and meeting regulatory standards. Selection of the appropriate packaging material is based on factors like the route of administration, physical form of the product, stability requirements, and cost considerations.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Quality control of packaging materials."
Thank you for reading.
we hope it was helpful to you.
UIPS,PU team
This document discusses quality control testing standards and procedures for pharmaceutical packaging materials. It outlines tests for various packaging components like glass containers, plastic packaging, and rubber stoppers. Key tests described include appearance and dimensional checks, compatibility testing, chemical resistance tests like powdered glass tests and water attack tests, sterility validation tests for sterile products, and non-sterile product validation tests. The document emphasizes that quality control testing is important to ensure packaging and components are defect-free and can safely contain drug products.
This document discusses quality control testing for packaging materials, specifically glass and plastic containers. It defines quality control and the different types of packaging (primary, secondary, tertiary). It then describes various quality control tests performed on glass containers, including tests for chemical resistance, hydrolytic resistance, thermal shock resistance, and tests for containers used for injectable preparations. Similar tests are described for plastic containers, with the overall goal of ensuring packaging materials meet specifications before use to protect drug quality, stability, and efficacy.
The document discusses various quality control tests performed on pharmaceutical packaging materials like glass containers, closures, collapsible tubes, metallic tins, strips, blisters, and paper and board. It describes tests such as chemical resistance testing, hydrolytic resistance testing, arsenic testing, thermal shock testing, internal bursting pressure testing, and leakage testing for glass containers. Similar tests are described for other packaging materials to check properties like sterility, fragmentation resistance, self-sealability, dimensions, cleanliness, and moisture penetration resistance. The purpose of these tests is to ensure that the packaging materials meet quality standards and do not interact or leach components that can contaminate the pharmaceutical products stored within.
This document discusses quality control tests for various pharmaceutical packaging materials including glass containers, closures, collapsible tubes, metallic tins, strips, blisters, and paper/board. It describes tests to evaluate the chemical resistance, hydrolytic resistance, arsenic content, thermal shock resistance, internal bursting pressure, and leakage of glass containers. Similar tests are described for evaluating the sterility, fragmentation, self-sealability, pH, light absorption, and residue of closures. Tests for collapsible tubes include leakage testing, collapsibility testing, and lacquer curing/compatibility. Dimensional measurements and cleanliness checks are discussed for metallic tins. Vacuum testing is described for quality control of strips and
Qc test for plastics,metallic tins,closures, collapsible tubes, secondary pac...himanshu kamboj
b pharma 6th sem
pharmaceutical quality assurance
Introduction
Types of pharmaceutical packaging
Packaging materials
Quality control test for plastic
Quality control test for closures
Quality control of collapsible tubes
Quality control of metallic tins
QC test for secondary packaging materials
This document discusses quality control testing for various packaging materials used in the pharmaceutical industry, including glass, plastic, paper/cardboard, rubber, metals and foils. It provides details on specific tests for each material. For example, for glass it describes light transmission testing, hydrolytic resistance testing and powdered glass testing. For plastic, it outlines leakage testing, collapsibility testing and water vapor permeability testing. The document aims to guide testing to ensure that packaging materials meet quality standards.
Similar to PD- stability assesment of containers and closures.pptx (20)
Bacterial enzymes and industrial enzymes are important for many industries. Bacterial enzymes like amylase, protease, and cellulase are produced through fermentation of bacteria like Bacillus subtilis. The production process involves selecting a microorganism, isolating it in pure culture, improving the strain, formulating growth media, fermentation, and recovering the enzymes. Industrial enzymes have various applications in industries like textiles, detergents, food, and pulp/paper. Examples are amylases for desizing fabrics and dish detergents, proteases for removing stains, and cellulases for biopolishing textiles.
Microbial interaction
Microorganisms interacts with each other and can be physically associated with another organisms in a variety of ways.
One organism can be located on the surface of another organism as an ectobiont or located within another organism as endobiont.
Microbial interaction may be positive such as mutualism, proto-cooperation, commensalism or may be negative such as parasitism, predation or competition
Types of microbial interaction
Positive interaction: mutualism, proto-cooperation, commensalism
Negative interaction: Ammensalism (antagonism), parasitism, predation, competition
I. Mutualism:
It is defined as the relationship in which each organism in interaction gets benefits from association. It is an obligatory relationship in which mutualist and host are metabolically dependent on each other.
Mutualistic relationship is very specific where one member of association cannot be replaced by another species.
Mutualism require close physical contact between interacting organisms.
Relationship of mutualism allows organisms to exist in habitat that could not occupied by either species alone.
Mutualistic relationship between organisms allows them to act as a single organism.
Examples of mutualism:
i. Lichens:
Lichens are excellent example of mutualism.
They are the association of specific fungi and certain genus of algae. In lichen, fungal partner is called mycobiont and algal partner is called
II. Syntrophism:
It is an association in which the growth of one organism either depends on or improved by the substrate provided by another organism.
In syntrophism both organism in association gets benefits.
Compound A
Utilized by population 1
Compound B
Utilized by population 2
Compound C
utilized by both Population 1+2
Products
In this theoretical example of syntrophism, population 1 is able to utilize and metabolize compound A, forming compound B but cannot metabolize beyond compound B without co-operation of population 2. Population 2is unable to utilize compound A but it can metabolize compound B forming compound C. Then both population 1 and 2 are able to carry out metabolic reaction which leads to formation of end product that neither population could produce alone.
Examples of syntrophism:
i. Methanogenic ecosystem in sludge digester
Methane produced by methanogenic bacteria depends upon interspecies hydrogen transfer by other fermentative bacteria.
Anaerobic fermentative bacteria generate CO2 and H2 utilizing carbohydrates which is then utilized by methanogenic bacteria (Methanobacter) to produce methane.
ii. Lactobacillus arobinosus and Enterococcus faecalis:
In the minimal media, Lactobacillus arobinosus and Enterococcus faecalis are able to grow together but not alone.
The synergistic relationship between E. faecalis and L. arobinosus occurs in which E. faecalis require folic acid
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Anti-Universe And Emergent Gravity and the Dark UniverseSérgio Sacani
Recent theoretical progress indicates that spacetime and gravity emerge together from the entanglement structure of an underlying microscopic theory. These ideas are best understood in Anti-de Sitter space, where they rely on the area law for entanglement entropy. The extension to de Sitter space requires taking into account the entropy and temperature associated with the cosmological horizon. Using insights from string theory, black hole physics and quantum information theory we argue that the positive dark energy leads to a thermal volume law contribution to the entropy that overtakes the area law precisely at the cosmological horizon. Due to the competition between area and volume law entanglement the microscopic de Sitter states do not thermalise at sub-Hubble scales: they exhibit memory effects in the form of an entropy displacement caused by matter. The emergent laws of gravity contain an additional ‘dark’ gravitational force describing the ‘elastic’ response due to the entropy displacement. We derive an estimate of the strength of this extra force in terms of the baryonic mass, Newton’s constant and the Hubble acceleration scale a0 = cH0, and provide evidence for the fact that this additional ‘dark gravity force’ explains the observed phenomena in galaxies and clusters currently attributed to dark matter.
The cost of acquiring information by natural selectionCarl Bergstrom
This is a short talk that I gave at the Banff International Research Station workshop on Modeling and Theory in Population Biology. The idea is to try to understand how the burden of natural selection relates to the amount of information that selection puts into the genome.
It's based on the first part of this research paper:
The cost of information acquisition by natural selection
Ryan Seamus McGee, Olivia Kosterlitz, Artem Kaznatcheev, Benjamin Kerr, Carl T. Bergstrom
bioRxiv 2022.07.02.498577; doi: https://doi.org/10.1101/2022.07.02.498577
PPT on Direct Seeded Rice presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
PPT on Alternate Wetting and Drying presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆Sérgio Sacani
Context. The early-type galaxy SDSS J133519.91+072807.4 (hereafter SDSS1335+0728), which had exhibited no prior optical variations during the preceding two decades, began showing significant nuclear variability in the Zwicky Transient Facility (ZTF) alert stream from December 2019 (as ZTF19acnskyy). This variability behaviour, coupled with the host-galaxy properties, suggests that SDSS1335+0728 hosts a ∼ 106M⊙ black hole (BH) that is currently in the process of ‘turning on’. Aims. We present a multi-wavelength photometric analysis and spectroscopic follow-up performed with the aim of better understanding the origin of the nuclear variations detected in SDSS1335+0728. Methods. We used archival photometry (from WISE, 2MASS, SDSS, GALEX, eROSITA) and spectroscopic data (from SDSS and LAMOST) to study the state of SDSS1335+0728 prior to December 2019, and new observations from Swift, SOAR/Goodman, VLT/X-shooter, and Keck/LRIS taken after its turn-on to characterise its current state. We analysed the variability of SDSS1335+0728 in the X-ray/UV/optical/mid-infrared range, modelled its spectral energy distribution prior to and after December 2019, and studied the evolution of its UV/optical spectra. Results. From our multi-wavelength photometric analysis, we find that: (a) since 2021, the UV flux (from Swift/UVOT observations) is four times brighter than the flux reported by GALEX in 2004; (b) since June 2022, the mid-infrared flux has risen more than two times, and the W1−W2 WISE colour has become redder; and (c) since February 2024, the source has begun showing X-ray emission. From our spectroscopic follow-up, we see that (i) the narrow emission line ratios are now consistent with a more energetic ionising continuum; (ii) broad emission lines are not detected; and (iii) the [OIII] line increased its flux ∼ 3.6 years after the first ZTF alert, which implies a relatively compact narrow-line-emitting region. Conclusions. We conclude that the variations observed in SDSS1335+0728 could be either explained by a ∼ 106M⊙ AGN that is just turning on or by an exotic tidal disruption event (TDE). If the former is true, SDSS1335+0728 is one of the strongest cases of an AGNobserved in the process of activating. If the latter were found to be the case, it would correspond to the longest and faintest TDE ever observed (or another class of still unknown nuclear transient). Future observations of SDSS1335+0728 are crucial to further understand its behaviour. Key words. galaxies: active– accretion, accretion discs– galaxies: individual: SDSS J133519.91+072807.4
2. STABILTY ASSESMENT OF CONTAINERS AND CLOSURES
Assignment of
PRODUCT DEVELOPMENT
PHS CC 1202
Session 2023-2024
Department of Pharmaceutical Sciences
Dr. Harisingh Gour Vishwavidyalaya,Sagar, (M.P.)
(A Central University)
Supervisors:
PROF. VANDANASONI
PROF. SANJAYK. JAIN
DR. DHARMENDRA JAIN
Submitted by:
ARYA OJHA
Y23254025
3. ACKNOWLEGEMENT
Throughout my assignment, I truly appreciate the help and encouragement I received from my teachers
PROF. VANDANA SONI, PROF. S.K. JAIN and DR. DHARMENDRA JAIN .
4. INTRODUCTION :
• Pharmaceutical packaging can be defined as the economical means of providing presentation,
protection, identification , information, containment, convenience, compliance, integrity and stability of
the product.
• The selection of a package therefore begins with a determination of the product’s physical and
chemical characteristics, its protective needs, and its marketing requirements.
ROLE OF
PACKAGING:
Protection against
- light
- reactive gases
- moisture
- microbes
- physical damage
- adulteration
-
- Presentation
- Identification
- Information
- Compatible
- Convenience
5. The materials selected must have following characteristics:
They must protect the
preparation from
environmental
conditions.
They must not be
reactive with the
product.
They must not impart
to the product tastes
or odors.
Must be non-toxic.
They must be “FDA”
approved.
They must meet
applicable tamper
resistance
requirements.
They must be adaptable
to commonly employed
high-speed packaging
equipment.
6. Types of containers:
Well – closed containers A well-closed container protects the
contents from loss during
transportation, handling, storage or
sale.
Single dose containers : These containers are used to supply
only one of medicament and hold
generally parenteral products.
E.g. ampoules and vials
Multi dose containers: These containers allow the withdrawal
of dose at various intervals without
changing the strength, quality or purity
of remaining portion. These containers
hold more than one dose and are used
for injectables. E.g. vials
7. Light-resistant containers: These containers protect the
medicament from harmful effects of
light. These containers are used to
store those medicaments which are
photo-sensitive.
Air-tight containers: These are also called hermetic
containers. These containers have air-
tight sealing or closing. These
containers protect the products from
dust, moisture and air.
Aerosol containers: These containers are used to hold
aerosol products. These containers
have adequate mechanical strength in
order to bear the pressure of aerosol
packing.
8. Types of Packaging:
Primary Packaging :
- Glass bottle jars
- Plastic bottles
- Strip packs
-Pouches
-Ointment tubes
-Vials and Ampoules
Primary packaging is the
material that envelopes the
product and holds it. This usually
is the smallest unit of
distribution or use and is the
package which is in direct
contact with the contents.
Secondary Packaging : Is outside the primary packaging-
perhaps used to group primary
packages together.
Tertiary Packaging : Is used for bulk handling,
warehouse storage and transport
shipping. The most common form is
a palletized unit load that packs
tightly into the container.
9. Qualities of good container:
• The container must be neutral towards the material which is stored in it.
• The container must not interact physically or chemically with the substance which it holds.
• It should help in maintaining the stability of product against the environmental factors which causes its
deterioration.
• It should be made of materials which can withstand wear and tear during normal handling.
• It should be able to withstand changes in pressure and temperature.
• The materials used for making of the container must be non-toxic
10. Materials used for making of containers:
GLASS-
e.g., Bottles, vials, ampules, syringes, i.v. containers, aerosol containers.
PLASTIC-
e.g., Bottles, pouches, tapes, tubes, aerosol containers, laminates.
12. Closures: A closure is the part of the package which prevent the contents from escaping and allow no
substance to enter the container.
Made up of :
Rubber
Plastics
Metals
Materials used for secondary packaging:
Papers
Cardboards
13. 1. Chemical resistance test
a)Powdered attack test
b)Water attack test
2. Hydrolytic resistance test
3. Arsenic test
4. Thermal shock test
5. Internal bursting pressure test
Stability test of glasses:
14. • Powdered glass test:
It is done to estimate the amount of alkali leached from the powdered glass, which happens at
elevated temperatures.
The decanted liquid is titrated with 0.02N H2SO4 using methyl red as
indicator.
It is autoclaved at 121°C for 30 min and cooled and decanted.
10 gm of the sample is washed with acetone and dried. 50 ml of purified
water is added to the dried sample .
The containers are grinded in a mortar to a fine powder and passed through
sieve no. 20 & 50.
Sample containers are rinsed with purified water and dried.
LIMITS:
TEST CONTAINER VOL OF 0.02N
H2SO4 (ML)
Powdered glass
test
Type I
(borosilicate
glass)
Type II (soda-
lime glass)
Type N.P
(general
purpose soda-
lime glass)
1.0
8.5
15.0
15. • Water attack test:
This test is for type II glass. The principle involved in this is whether the alkali leaches from surface of
container.
The volume of H2SO4 consumed is recorded and compared with limits.
Then it is cooled, and liquid is decanted.
Decanted liquid is titrated with 0.02N H2SO4 using methyl red as an indicator
It is then autoclaved at 121°C for 30 min.
It is then filled with water upto 90% of its capacity
The container is rinsed thoroughly with high purity water. .
LIMITS:
TEST CONTAINER VOL OF 0.02N
H2SO4 (ML)
Water attack test Type II (soda-lime
glass)
100 ml
Less than 100
ml
0.7
0.2
16. • Hydrolytic resistant test:
This test is directly related to the stability of pharmaceuticals packed in it.
Test 1: Type I and Type II glass containers to distinguish from Type III glass containers.
Test 2: Type I and Type II glass containers where it is necessary to determine whether the high hydrolytic
resistance is due to the chemical composition or the surface treatment.
LIMITS:
NOMINAL CAPACITY OF
CONTAINER (ml)
NO. OF CONTAINERS THAT CAN
BE USED
VOL OF TEST SOLUTION FOR
TITRATION
Upto 3 At least 20 25.0
5 or less At least 10 50.0
6 to 30 At least 5 50.0
More than 30 At least 3 100.0
17. • Test 1:
A blank titration is performed with water and the difference between the titration represents the volume of HCl consumed by the test solution.
This test solution is titrated with 0.01M HCl using methyl red as an indicator (methyl red is red in alkaline pH and pink in acidic).
The container are removed from autoclave, cooled and the liquids are combined in a conical flask and the volume is measured.
The temp. is lowered from 121°C to 100°C over 40 min.
The temp. is maintained at 121°C to 122°C for 60 mins.
The temp. is risen from 100°C to 121°C over 20 mins.
Vials and bottles are covered and autoclaved at 100°C for 10 mins and the steam is allowed to displace from the vent cork.
Each container is rinsed at least three times with CO2 free water and filled with the same to their filling volume.
• Test 2:
Rest procedure are same as in test 1.
Empty containers and rinse 5 times with water.
Rinse the container twice with water and fill completely with 4% v/v solution of Hydrofluoric acid and allow to stand at room temperature for 10 mins.
18. • Arsenic test:
Limits:- The absorbance of the test solution should be less than the absorbance obtained using 0.1 ml of arsenic standard solution (10
ppm
It is cooled and absorbance is measured at 840nm. A Blank test is performed with 10 ml hydrogen molybdate.
10 ml of hydrogen molybdate is added and refluxed for 25 mins
To it 10 ml of HNO3 is added and dried in an oven at 130°C.
10 ml from the final combined volume is pipetted out.
The containers are cooled, and the liquids are combined, and volume measured.
The temp. is risen from 100°C to 121°C over 20 mins. The temp. is maintained at 121°C to 122°C for 60 mins.
Containers are covered and autoclaved at 100°C for 10 mins.
The inner and outer surface of container is washed with fresh distilled water for 5 min.
This test is for glass containers intended for aqueous parenteral.